Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn M Marshall

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Pharmacogenetics and Genomics|February 15, 2011
ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcriptMarina Pajic, Jayne Murray, Glenn M Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemiaStephen J Laughton, Lesley J Ashton, Edward Kwan, et al.
Molecules (Basel, Switzerland)|March 22, 2020
Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC InhibitorsMurat Bingul, Greg M Arndt, Glenn M Marshall, et al.
Bioorganic & Medicinal Chemistry|October 24, 2012
Synthesis of retinoid enhancers based on 2-aminobenzothiazoles for anti-cancer therapyChristopher R Gardner, Belamy B Cheung, Jessica Koach, et al.
Current Protocols|November 26, 2021
A Primer for Assessing the Pathology in Mouse Models of NeuroblastomaAndrew J Gifford, Jayne Murray, Jamie I Fletcher, et al.
Archives of Disease in Childhood|September 3, 2021
School academic performance of children hospitalised with a chronic conditionNan Hu, Joanna Fardell, Claire E Wakefield, et al.
Pharmacogenetics and Genomics|August 19, 2007
Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastomaLesley J Ashton, Jayne E Murray, Michelle Haber, et al.
Nature Reviews. Cancer|April 11, 2018
Too many targets, not enough patients: rethinking neuroblastoma clinical trialsJamie I Fletcher, David S Ziegler, Toby N Trahair, et al.
Journal of Paediatrics and Child Health|August 5, 2025
Establishing Research Priorities for Children Living With Chronic Health Conditions: A Value-Weighting Study by Australian CaregiversLouise Fisher, Macken Stirling, Renee Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
Prognostic significance of promoter DNA methylation in patients with childhood neuroblastomaDiana T Lau, Luke B Hesson, Murray D Norris, et al.
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Pharmacogenetics and Genomics|February 15, 2011
ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcriptMarina Pajic, Jayne Murray, Glenn M Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemiaStephen J Laughton, Lesley J Ashton, Edward Kwan, et al.
Molecules (Basel, Switzerland)|March 22, 2020
Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC InhibitorsMurat Bingul, Greg M Arndt, Glenn M Marshall, et al.
Bioorganic & Medicinal Chemistry|October 24, 2012
Synthesis of retinoid enhancers based on 2-aminobenzothiazoles for anti-cancer therapyChristopher R Gardner, Belamy B Cheung, Jessica Koach, et al.
Current Protocols|November 26, 2021
A Primer for Assessing the Pathology in Mouse Models of NeuroblastomaAndrew J Gifford, Jayne Murray, Jamie I Fletcher, et al.
Archives of Disease in Childhood|September 3, 2021
School academic performance of children hospitalised with a chronic conditionNan Hu, Joanna Fardell, Claire E Wakefield, et al.
Pharmacogenetics and Genomics|August 19, 2007
Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastomaLesley J Ashton, Jayne E Murray, Michelle Haber, et al.
Nature Reviews. Cancer|April 11, 2018
Too many targets, not enough patients: rethinking neuroblastoma clinical trialsJamie I Fletcher, David S Ziegler, Toby N Trahair, et al.
Journal of Paediatrics and Child Health|August 5, 2025
Establishing Research Priorities for Children Living With Chronic Health Conditions: A Value-Weighting Study by Australian CaregiversLouise Fisher, Macken Stirling, Renee Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
Prognostic significance of promoter DNA methylation in patients with childhood neuroblastomaDiana T Lau, Luke B Hesson, Murray D Norris, et al.
Pageof 18